A pilot study was performed in patients with recurrent back pain after spinal fusion surgery to evaluate the ability of 18F-NaF PET/CT imaging to correctly identify those requiring surgical intervention and to locate a site amenable to surgical intervention.
In this prospective study 22 patients with recurrent back pain after spinal surgery and with equivocal findings on physical examination and CT were enrolled for evaluation with 18F-NaF PET/CT. All PET/CT images were prospectively reviewed with the primary objective of identifying or ruling out the presence of lesions amenable to surgical intervention. The PET/CT results were then validated during surgical exploration or clinical follow-up of at least 15 months.
Abnormal 18F-NaF foci were found in 16 of the 22 patients, and surgical intervention was recommended. These foci were located at various sites: screws, cages, rods, fixation hardware, and bone grafts. In 6 of the 22 patients no foci requiring surgical intervention were found. Validation of the results by surgery (15 patients) or on clinical follow-up (7 patients) showed that 18F-NaF PET/CT correctly predicted the presence of an abnormality requiring surgical intervention in 15 of 16 patients and was falsely positive in 1 of 16.
In this initial investigation, 18F-NaF PET/CT imaging showed potential utility for evaluation of recurrent symptoms after spinal fusion surgery by identifying those patients requiring surgical management.
The primary objective of this initial study was to evaluate 18F-sodium fluoride (18F-NaF) PET/CT scanning for helping to correctly manage patients after spinal fusion surgery (arthrodesis). Spinal fusion is a common procedure performed to treat a variety of spine conditions including degenerative disease, spondylolisthesis, and vertebral deformities [1, 2]. After spinal fusion, suboptimal outcomes may be caused by infection, hardware loosening, non-union of fused vertebrae, and/or incomplete growth of bone grafts.
Patients who have recurrent symptoms caused by these complications after spinal fusion surgery undergo standard evaluation by clinical examination and conventional imaging. However, whether a patient requires surgical intervention is difficult to ascertain because CT and/or MRI will often show extensive and nonspecific postoperative changes [3, 4]. The physiology of 18F-NaF is similar to that of 99mTc-MDP used in traditional bone scanning. However, 18F-NaF PET/CT is significantly faster (both uptake and acquisition), provides superior spatial resolution, and is widely available in the US and Europe [5–7].
This was a pilot investigation of the ability of 18F-NaF PET/CT to identify spinal sites requiring surgical revision after fusion surgery and therefore help orthopedists stratify patients into surgical or conservative management. Validation of the PET/CT results was based on findings on surgery or clinical follow-up of at least 15 months.
Materials and methods
This study was conducted as a clinical trial and was fully compliant with the approval from the ethics committees at our respective institutions. This trial was a single-cohort prospective study of consecutive patients enrolled at two institutions between April 2009 and August 2011. The inclusion criteria consisted of identifying patients who had recurrent symptoms after prior spinal fusion surgery. Additionally, these patients had had a clinical evaluation, physical examination and CT scan that had failed to identify a specific contributing source of the symptoms, and the course of management remained uncertain. Other imaging such as MRI, bone scanning and plain radiography were not required. However, if a patient had undergone these examinations, then the inclusion criteria stipulated that these also did not adequately elucidate the course of management. Pediatric patients, pregnant women and patients unfit for additional surgery were excluded.
Included in the study were 22 patients (16 women, 6 men; age range 36–80 years) with recurrent back pain after spinal surgery and an equivocal physical examination and conventional imaging. The patients underwent 18F-NaF PET/CT at Mãe de Deus Hospital in Porto Alegre, Brazil (18 patients) and Stanford University Hospital (4 patients). All 18F-NaF PET/CT scanning was performed at least 4 months after the most recent surgery (range 4–96 months after surgery, median 21 months; Table 1) and all scanning was performed within 4 months of presentation with recurrent symptoms.
The PET/CT system used at Mãe de Deus Hospital was a Phillips Gemini TF scanner with a Brilliance 16-slice CT scanner and at Stanford University Hospital was a GE Discovery 600 PET/CT system with a 16-slice CT scanner. The CT part of the PET/CT acquisition was designed to be equivalent to a stand-alone diagnostic CT protocol optimized for bone/spine imaging: 1.25–2 mm slice thickness, 1 mm increment, 100–140 kV, 180–230 mAs, and matrix size 512 × 512 pixels. Intravenous contrast agent was not utilized. The PET scanning protocol included injection of 222–370 MBq (6–10 mCi) 18F-NaF followed by 45 min for tracer uptake. PET scanning consisted of 150–250 s per bed position acquisition time. The number of bed positions varied from five to eight depending on the amount of spine to be covered. Images were reconstructed using the ordered subset expected maximization algorithm with four to eight iterations.
A nuclear medicine physician and a radiologist with musculoskeletal expertise reviewed all PET/CT images together with the primary objective of identifying or ruling out the presence of lesions amenable to surgical intervention. The most important feature for identifying an abnormality requiring surgery was focal and well-circumscribed activity clearly above the background spine that coregistered on the CT image with sites typical for hardware failure or pseudoarthrosis (such as the ends of fixation rods and cages, screw shafts, bone grafts). Foci without any significant CT abnormality were downgraded in suspicion. Standardized uptake values (SUV) were used to compare individual foci against background spine activity, but an absolute threshold level for positivity was not used. Clinical history and prior CT imaging were also taken into consideration. PET images not corrected for attenuation were analyzed when needed to identify attenuation artifacts caused by the metallic implants. Incidental foci such as osteophytes, benign bone lesions, and mild degenerative changes were noted but were not formally tabulated. Results of 18F-NaF PET/CT scanning were then communicated to the referring orthopedist and tabulated in detail for analysis and validation (Table 1).
Clinical management and outcome measurement
Based primarily on 18F-NaF PET/CT imaging, the patient then underwent either surgical exploration (with possible intervention), or conservative management. Surgical exploration consisted of the orthopedic surgeon probing and manually testing the exact region for loosening and hardware failure at sites of abnormal tracer activity. Further, extracted hardware and bone tissue underwent histopathological analysis for evidence of infection or bone necrosis. Conservative management included: regional anesthetic nerve blockade (to provide palliative short-term relief), physical therapy, medication, and bed rest.
PET/CT abnormalities were considered true positive if they were confirmed on surgery or if by the 15-month clinical follow-up other adjunctive examinations and data were wholly consistent with a surgically relevant lesion. PET/CT foci were considered false positive if no operable abnormality was found on surgery or if symptoms improved without surgical intervention. Negative PET/CT scans were considered true negative if symptoms improved with nonsurgical management and/or were corroborated as stable or resolved on adjunctive imaging examinations such as CT and MRI. Negative PET/CT scans were considered false negative if surgical intervention was ultimately required.
The intensity of the patient’s pain was graded from 0 to 4 prior to initiation of treatment and at the 15-month follow-up as follows: 0 no pain, 1 mild pain, 2 moderate pain, 3 severe pain, 4 severe and debilitating pain.
A standard 2 × 2 contingency table was used to calculate the sensitivity and specificity on a patient-by-patient basis. Findings on surgery or the 15-month clinical follow-up were utilized as the gold standard.
In total, 116 patients were evaluated for recurrent pain during the study period. Of these, standard clinical evaluation and imaging produced an adequate management plan in 64 patients (55 %) while 52 patients (45 %) did not have conclusive results and met the inclusion criteria for 18F-NaF PET/CT. Overall, 22 patients were enrolled and consented to the study while the remaining 30 did not consent to imaging for a variety of reasons including fear of extra radiation, schedule conflict, and/or additional time commitment. Some patients had very long-lasting relief from their original surgery while others presented soon after surgery with new or recurrent symptoms. Also not unexpectedly, the symptomatology may have differed at the initial spinal fusion and at the time of the follow-up PET/CT examination including the exact location and/or the descriptive quality of the complaint. Otherwise, the patient characteristics did not change. All patients had prior multilevel hardware placement exhibiting varying degrees of abnormal anatomical findings where postsurgical healing versus pathological findings could not be clearly differentiated on CT alone. The interpreting physicians found that 16 of the 22 patients had an 18F-NaF PET/CT scan that had at least one abnormality amenable to surgical intervention (Figs. 1 and 2). A total of 21 foci were identified amongst these 16 patients. The abnormal foci were located at the following sites: screws (six), cages/rods/fixation hardware (six), and bone grafts (nine) (Table 1). The maximum SUV (SUVmax) of these foci ranged from 7.4 to 23.5 (SUVmax of all foci: average 15.9, median 14.2). The background SUVmax was recorded from the closest comparable vertebral structure without a lesion and ranged from 4.4 to 5.9 (average 5.2, median 5.4).
Of the 16 patients with abnormal PET/CT results, 15 went on to surgical exploration. The orthopedist found abnormalities in 14 of 15 of these patients that correlated precisely with the PET/CT findings and led to repair of the hardware or spine. In one patient (patient 13, Table 1) a biopsy of a bone graft revealed normal bone growth and the PET/CT result was therefore false positive (Table 1). One patient (patient 20, Table 1) with PET/CT abnormalities was not receptive to surgical intervention and was therefore followed clinically rather than subjected to surgery (Table 1). A repeat CT scan at 15 months revealed a graft fracture and hardware loosening and the PET/CT result was therefore true positive.
Of the 22 patients, 6 did not have any foci on 18F-NaF PET/CT that appeared amenable to surgery and conservative treatment was recommended. In these normal-appearing patients, the SUVmax was recorded from skeletal sites that had undergone surgery, and the values ranged from 5.8 to 7.3 (SUVmax: average 6.4, median 6.2). The background SUVmax values obtained from comparable spinal structures external to the surgical sites ranged from 5.2 to 6.6 (average 5.6, median 5.4). In all six patients, pain had improved without surgery at the 15-month follow-up and the imaging results were scored as true negative (Table 1).
On a patient-by-patient basis, the sensitivity and specificity of the ability of 18F-NaF PET/CT to identify the presence of an abnormality requiring surgical intervention were 100 % (95 % CI 78.2–100 %) and 85.7 % (95 % CI 42.1–99.6 %), respectively. On a lesion-by-lesion basis, 20 of the 21 abnormal foci (in 16 subjects) identified by 18F-NaF PET/CT were confirmed as true positive while 1 of 20 was false positive.
18F-NaF PET/CT imaging appeared to provide accurate adjunctive information to the standard work-up. Specifically, 14 of 15 patients who underwent surgical exploration based on PET/CT results were confirmed to have lesions requiring surgical intervention by either histopathology or direct manual probing. Overall, 15 of 16 patients were correctly identified by PET/CT as having a lesion requiring surgery after initial evaluation was equivocal regarding the need for surgery. Conversely, all of the six patients with PET/CT results indicating that surgery was not required were found after 15 months of follow-up to have improved (by clinical assessment and reported pain).
It should be noted that the timing of postoperative inflammation and its effect on 18F-NaF PET/CT cannot be deduced from this project. The single false-positive result in this study occurred in a patient (patient 13, Table 1) who underwent scanning just 4 months after spinal fusion. Nevertheless, most of the postoperative spine in all patients showed normal 18F-NaF activity compared to background vertebrae despite extensive hardware placement, suggesting that when given enough time, the tracer has relatively little nonspecific uptake at sites of prior surgery (Figs. 1, 2 and 3).
Our results substantiate and expand on those of a recent study by Fischer et al. that showed the potential of 18F-NaF PET/CT for characterizing orthopedic hardware incorporation . However, this prior study lacked outcome data and abnormalities found on 18F-NaF PET/CT were described without follow-up information to validate the imaging results. The literature on the use of 18F-NaF PET/CT for evaluating the postoperative spine is otherwise very scant. The use of SPECT tracers such as 99mTc-MDP has been described more extensively, although very few studies included integrated SPECT/CT which would be more comparable to PET/CT. A contemporary study by Damgaard et al. using 99mTc-MDP SPECT/CT suggested possible utility for detecting lack of fusion of metallic implants, but this study suffered from the smallness of the cohort which comprised only nine subjects and a retrospective design . A review by Scharf in 2010 also noted the potential for integrated SPECT/CT in a variety of conditions including evaluation of spinal fusion . However, this was not a formal scientific evaluation of data but merely a descriptive report of two case studies. Studies prior to 2000 investigated the utility of 99mTc-MDP SPECT (without integrated CT) more comprehensively [11, 12]. A 1987 study by Slizofski et al. prospectively evaluated 15 symptomatic patients following lumbar fusion and found SPECT to have a sensitivity and specificity of 78 % and 83 %, respectively, for identifying offending osseous sites of recurrent pain . A larger study by Gates and McDonald showed similar results in 63 patients following lumbar surgery . While a statistical analysis was not presented, the authors concluded that SPECT imaging is particularly useful for excluding bony causes of recurrent back pain while positive lesions are helpful for identifying causative abnormalities such as facet arthropathy and pseudoarthrosis. In both studies (Slizofski et al.  and Gates and McDonald ), validation of SPECT results utilized findings at surgery as well as other imaging. However, the added value of SPECT versus existing conventional imaging, such as CT, plain radiography or MRI, was not directly addressed, and it is not clear whether SPECT would aid treatment decisions beyond conventional work-up. There are no studies that have directly compared 18F-NaF PET/CT with 99mTc-MDP SPECT or SPECT/CT in the same cohort of patients although, as stated in the Introduction, 18F-NaF PET/CT is superior to 99mTc-MDP SPECT/CT in terms of speed and image quality.
The pilot cohort investigated in our project was small and our high reported sensitivity and specificity should be viewed with caution. Nevertheless, the data and image quality appear promising and a larger clinical evaluation is warranted, including possibly comparing the outcomes of two management approaches in different cohorts, CT and one/CT and one without.
In this prospective pilot investigation of 22 patients, 18F-NaF PET/CT imaging demonstrated potential for aiding management of patients with recurrent pain after spinal fusion surgery by helping to correctly identify those requiring surgical intervention.
Elixhauser A, Andrews RM. Profile of inpatient operating room procedures in US hospitals in 2007. Arch Surg. 2010;145(12):1201–8.
Camillo FX. Arthrodesis of the spine. In: Canale ST, Beaty JH, editors. Campbell’s operative orthopaedics. 11th ed. Philadelphia: Mosby; 2007. p. 1851–74.
Young PM, Berquist TH, Bancroft LW, Peterson JJ. Complications of spinal instrumentation. Radiographics. 2007;27(3):775–89.
Grob D, Mannion AF. The patient’s perspective on complications after spine surgery. Eur Spine J. 2009;18 Suppl 3:380–5.
Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med. 2010;51(12):1826–9.
Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008;49(1):68–78.
Buck AK, Herrmann K, Stargardt T, Dechow T, Krause BJ, Schreyogg J. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. J Nucl Med. 2010;51(3):401–12. doi:10.2967/jnumed.108.059584.
Fischer DR, Zweifel K, Treyer V, Hesselmann R, Johayem A, Stumpe KD, et al. Assessment of successful incorporation of cages after cervical or lumbar intercorporal fusion with [(18)F]fluoride positron-emission tomography/computed tomography. Eur Spine J. 2011;20(4):640–8. doi:10.1007/s00586-010-1643-z.
Damgaard M, Nimb L, Madsen JL. The role of bone SPECT/CT in the evaluation of lumbar spinal fusion with metallic fixation devices. Clin Nucl Med. 2010;35(4):234–6. doi:10.1097/RLU.0b013e3181d18cdd.
Scharf S. SPECT/CT imaging in general orthopedic practice. Semin Nucl Med. 2009;39(5):293–307. doi:10.1053/j.semnuclmed.2009.06.002.
Slizofski WJ, Collier BD, Flatley TJ, Carrera GF, Hellman RS, Isitman AT. Painful pseudarthrosis following lumbar spinal fusion: detection by combined SPECT and planar bone scintigraphy. Skeletal Radiol. 1987;16(2):136–41.
Gates GF, McDonald RJ. Bone SPECT of the back after lumbar surgery. Clin Nucl Med. 1999;24(6):395–403.
The authors wish to thank Jarrett Rosenberg, PhD, for his work on the biostatistics in this project, and also Luciane Boanova for her work in managing all of the imaging data and production of key images.
Conflicts of interest
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Quon, A., Dodd, R., Iagaru, A. et al. Initial investigation of 18F-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery. Eur J Nucl Med Mol Imaging 39, 1737–1744 (2012). https://doi.org/10.1007/s00259-012-2196-7
- Fluoride PET/CT
- Spinal fusion